Sydney-bound Etihad flight with 349 people onboard makes emergency landing

Agencies

October 14, 2017

Canberra, Oct 14: An Etihad Airways flight bound for Sydney from Abu Dhabi made an emergency landing in the Australian city of Adelaide on Saturday, after pilots noticed a smoke alarm on board.

The Boeing 777 aircraft was carrying 349 people when pilots made the decision to divert to Adelaide at about 5 aam, Xinhua news agency reported.

In a statement detailing the diversion, a spokesperson from Etihad Airways said the decision was made with the safety of all passengers and crew in mind after a smoke alarm warning light was illuminated.

The spokesperson added that Etihad Airways flight EY450 would undergo a safety check before it takes to the skies once again.

The fire brigade was kept on alert. Passengers were told they would be making their way to Sydney on domestic flights.

Comments

Add new comment

Coastaldigest.com reserves the right to delete or block any comments.
Coastaldigset.com is not responsible for its readers’ comments.
Comments that are abusive, incendiary or irrelevant are strictly prohibited.
Please use a genuine email ID and provide your name to avoid reject.

AstraZeneca to withdraw Covid-19 vaccine globally as demand dips after admitting side effects

News Network

May 8,2024

AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic.

The company also said it would proceed to withdraw the vaccine Vaxzevria's marketing authorizations within Europe.

"As multiple, variant Covid-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.

According to media reports, the Anglo-Swedish drugmaker has previously admitted in court documents that the vaccine causes side-effects such as blood clots and low blood platelet counts.

The firm's application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the Telegraph, which first reported the development.

London-listed AstraZeneca began moving into respiratory syncytial virus vaccines and obesity drugs through several deals last year after a slowdown in growth as COVID-19 medicine sales declined.

Comments